AlphaFold predicted structure
ICOSLG · O75144

Mean pLDDT
82.6/ 100
Confident
302 residues
Confidence breakdown
- Very high(≥ 90)62%
- Confident(70–90)15%
- Low(50–70)7%
- Very low(< 50)16%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
inducible T cell costimulator ligand
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalimmunodeficiency 119
combined immunodeficiency
rheumatoid arthritis
Combined T and B cell immunodeficiency
hereditary disease
depressive disorder
severe combined immunodeficiency
cardiomyopathy
benign urinary system neoplasm
neoplasm
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
ICOS ligand
Ligand for the T-cell-specific cell surface receptor ICOS. Acts as a costimulatory signal for T-cell proliferation and cytokine secretion (PubMed:11007762, PubMed:11023515, PubMed:30498080). Also induces B-cell proliferation and differentiation into plasma cells. Could play an important role in mediating local tissue responses to inflammatory conditions, as well as in modulating the secondary immune response by co-stimulating memory T-cell function (By similarity). In endothelial cells, required for proper neutrophil transmigration in response to chemoattractants, such as CXCL8/IL8 or N-formyl-methionyl peptides (fMLP) (PubMed:30498080)
ICOSLG · O75144

Mean pLDDT
82.6/ 100
Confident
302 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0